Adelaide Research & Scholarship: Search

Search

Results 31-40 of 97 (Search time: 0.003 seconds).

previous
1
2
3
4
5
6
7
...
10
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2020	Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia	Thomson, D.W.; Shahrin, N.H.; Wang, P.P.S.; Wadham, C.; Shanmuganathan, N.; Scott, H.S.; Dinger, M.E.; Hughes, T.P.; Schreiber, A.W.; Branford, S.
	2021	Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia	Ochi, Y.; Yoshida, K.; Huang, Y.-J.; Kuo, M.-C.; Nannya, Y.; Sasaki, K.; Mitani, K.; Hosoya, N.; Hiramoto, N.; Ishikawa, T.; Branford, S.; Shanmuganathan, N.; Ohyashiki, K.; Takahashi, N.; Takaku, T.; Tsuchiya, S.; Kanemura, N.; Nakamura, N.; Ueda, Y.; Yoshihara, S.; et al.
	2018	Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells	Ross, D.; Pagani, I.; Shanmuganathan, N.; Kok, C.; Seymour, J.; Mills, A.; Filshie, R.; Arthur, C.; Dang, P.; Saunders, V.; Braley, J.; Yong, A.; Yeung, D.; White, D.; Grigg, A.; Schwarer, A.; Branford, S.; Hughes, T.
	2019	Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI	Shanmuganathan, N.; Branford, S.; Hughes, T.P.; Hiwase, D.
	2014	Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib	Olshen, A.; Tang, M.; Cortes, J.; Gonen, M.; Hughes, T.; Branford, S.; Quintás-Cardama, A.; Michor, F.
	2016	Validation of a rapid one-step high sensitivity real-time quantitative PCR system for detecting major BCR-ABL1 mRNA on an International Scale	Yoshida, C.; Nakamae, H.; Fletcher, L.; Koga, D.; Sogabe, T.; Matsumura, I.; Kanakura, Y.; Branford, S.; Naoe, T.
	2013	BCR-ABL1 kinase domain mutations may persist at very low levels for many years and lead to subsequent TKI resistance	Parker, W.; Yeoman, A.; Jamison, B.; Yeung, D.; Scott, H.; Hughes, T.; Branford, S.
	2016	BAM-matcher: a tool for rapid NGS sample matching	Wang, P.; Parker, W.; Branford, S.; Schreiber, A.
	2015	KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy	Yeung, D.; Tang, C.; Vidovic, L.; White, D.; Branford, S.; Hughes, T.; Yong, A.
	2019	Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission	Shanmuganathan, N.; Braley, J.A.; Yong, A.S.M.; Hiwase, D.K.; Yeung, D.T.; Ross, D.M.; Hughes, T.P.; Branford, S.